Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Sequential Whole Bladder Photodynamic Therapy (WBPDT) in the Management of Superficial Bladder Cancer

This study has been completed.
Sponsor:
Collaborators:
North Florida Foundation for Research and Education
Axcan Pharma
Information provided by (Responsible Party):
Unyime O. Nseyo, MD, North Florida/South Georgia Veterans Health System
ClinicalTrials.gov Identifier:
NCT00322699
First received: May 4, 2006
Last updated: October 25, 2012
Last verified: August 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2011
  Primary Completion Date: April 2010 (Final data collection date for primary outcome measure)